A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Significance: Chronic bacterial infections, such as those caused by Mycobacterium tuberculosis ( Mtb ), continue to claim the lives of millions of people. New antibiotics are needed to treat these infections, but their development is hindered by a lack of targets whose inhibition quickly eradicates bacterial pathogens and prevents the survival of drug-tolerant persisters. We describe a unique dual-control (DUC) switch that combines repression of transcription and controlled proteolysis to silence gene activities in Mtb . By conditionally inactivating Mtb ’s nicotinamide adenine dinucleotide synthetase, we demonstrate that the DUC switch can identify proteins that this pathogen requires for growth and nonreplicating persistence in vitro and during infections. Targeting such proteins holds the promise of yielding drugs that shorten the duration of antibacterial chemotherapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512 · cited 2×
“For the development of antibacterials, this need was initially thought to be addressable with recombinant genetic technologies that enabled both untargeted genome-wide mutations and targeted gene deletions (2).”
BackgroundLewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858
Griffin, J. E., Gawronski, J. D., DeJesus, M. A., Ioerger, T. R., Akerley, B. J., & Sassetti, C. M. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002251 · Cited by 1,048 · cited 1×
“Transposon mutagenesis identified nadD and nadE as required for optimal in vitro growth (26, 27).”
Fauvart, M., De Groote, V. N., & Michiels, J. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.030932-0 · Cited by 425
Berens, C., & Hillen, W. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03694.x · Cited by 261
Cited by
Metabolic principles of persistence and pathogenicity in Mycobacterium tuberculosis
Ehrt, S., Schnappinger, D., & Rhee, K. Y. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0013-4 · Cited by 296
Self-citationde Wet, T. J., Winkler, K. R., Mhlanga, M., Mizrahi, V., & Warner, D. F. (2020) · eLife · doi:10.7554/elife.60083 · Cited by 79
“The development of genetic tools for conditional knockdown mutagenesis via targeted gene silencing (utilizing engineered hypomorphic strains carrying promoter replacement and/or targeted protein-degradation mutations) has subsequently enabled gene-by-gene explorations of essential gene function (Kim et al., 2011; Kim…”
BackgroundRifat, D., Chen, L., Kreiswirth, B. N., & Nuermberger, E. L. (2021) · mBio · doi:10.1128/mbio.01049-21 · Cited by 76
Puckett, S., Trujillo, C., Eoh, H., Marrero, J., Spencer, J., Jackson, M., Schnappinger, D., Rhee, K., & Ehrt, S. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004144 · Cited by 72
“In FBA-DUC, fba contained a C-terminal DAS+4 tag and a plasmid in the phage tweety site that allowed inducible expression of SspB as described [31].”
BackgroundMethodInfluentialSelf-citationAdolph, C., McNeil, M. B., & Cook, G. M. (2022) · mBio · doi:10.1128/mbio.01672-22 · Cited by 32
Metadata
- Authors
- Kim, J.-H., O’Brien, K. M., Sharma, R., Boshoff, H. I. M., Rehren, G., Chakraborty, S., Wallach, J. B., Monteleone, M., Wilson, D. J., Aldrich, C. C., Barry, C. E., Rhee, K. Y., Ehrt, S., & Schnappinger, D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2013-11-04
- Volume
- 110
- Issue
- 47
- Pages
- 19095-19100
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2014375669
- Cited by
- 136
- References
- 5
- FWCI
- 8.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence. https://app.cochat.ai/papers/10.1073/pnas.1315860110
- The paper
- Kim, J.-H., O’Brien, K. M., Sharma, R., Boshoff, H. I. M., Rehren, G., Chakraborty, S., Wallach, J. B., Monteleone, M., Wilson, D. J., Aldrich, C. C., Barry, C. E., Rhee, K. Y., Ehrt, S., & Schnappinger, D. (2013). A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1315860110
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.